BloombergLean L·
Samsung Biologics to Raise $2.2 Billion to Fund PolyPeptide Deal
Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.
Read at Bloomberg →
Samsung Biologics Co. is seeking to raise about 3 trillion won ($2.2 billion) in a rights offering to fund its acquisition of PolyPeptide Group.
<iframe src="https://statesidedaily.com/embed/cluster/990044d69369e9c280d84783e33aa34abcd60c5f" width="100%" height="320" style="border:0;max-width:680px" loading="lazy" title="Samsung Biologics to Raise $2.2 Billion to Fund PolyPeptide Deal"></iframe>